Regulation of the cell cycle and PI3K/Akt/mTOR signaling pathway by tanshinone I in human breast cancer cell lines
Li Wang(Shandong Provincial Hospital), Jinhai Tang(Nanjing University of Chinese Medicine)
Cited by 59
Related Papers
A multiple center, open-label, single-arm, phase II clinical trial of MRG002, an HER2-targeted antibody-drug conjugate, in patients with HER2-low expressing advanced or metastatic breast cancer.
|Journal of Clinical Oncology|2022|36
Visible light assisted Fenton degradation of oxytetracycline over perovskite ErFeO3/porous g-C3N4 nanosheets p-n heterojunction
|Journal of environmental chemical engineering|2022|35